FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid Leukaemia By Ogkologos - November 26, 2024 712 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ASC4FIRST study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Excellence in cancer research nursing: Celebrating innovation during tough times October 7, 2022 A Rare Childbirth Complication Wiped This Woman’s Memory Of Giving Birth... December 4, 2019 News digest – ovarian cancer blood test, statins, spending review and... October 31, 2020 How to Get Started With Meditation During Cancer June 21, 2022 Load more HOT NEWS Blinatumomab Boosts Chemotherapy as Initial Treatment for Some Kids with ALL Children with Acute Lymphoblastic Leukemia Can Skip Radiation to the Brain Visits to Online Breast Cancer Communities Could Help Policy Makers and... COVID-19 Takes the Life of a Widowed Mother of 6 Who...
